Blade, Looks like the entire bio sector has been flattened, along with the other high growth sectors. I was thinking of going mainly with the broader bio sector ETFs like BBH, IBB rather than individual stocks. Very tempting based on the charts, assuming a long time horizon.
The market rotation away from growth is creating some nice bargains, not just biotech but other tech areas like cloud computing, cybersecurity, ai/robotics, etc. The charts still look like a 'falling knife' though, and tough to say where the actual bottom will be.
Any new bio stocks on your radar? Thanks
XENE is one that has held up well, with epilepsy related programs. Also the animal health/veterinary area seems like a decent sector, on the boring side but steadier than regular bio, though still down over 20% recently. Most of the big pharmas have held up reasonably well. But frustrating times for sure for the high growth riskier sectors..